The novel treatment of tirzepatide peptide represents a major development in the management of the condition. Different to existing medications, tirzepatide impacts multiple pathways – the GLP-1 hormone and the GIP hormone – resulting in enhanced sugar management and anticipated reduction in weight. Experts are studying its future effects and p